X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Aging and Disease

期刊標題檢索 AGING DIS 最新評論: How long does it usually take to wait for a review assignment? (2024-04-25)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Aging and Disease]您好,您是該頁面的第 72993 位訪客。

期刊簡介
期刊名稱Aging and Disease Aging and Disease
LetPub Score
7.4
50 ratings
Rate

Reputation
8.2

Influence
6.3

Speed
9.4

期刊簡稱AGING DIS
ISSN2152-5250
h-index38
CiteScore
CiteScoreSJRSNIPCiteScore Rank
14.601.9221.391
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pathology and Forensic Medicine
Q14 / 208
Category: Medicine
Subcategory: Geriatrics and Gerontology
Q13 / 116
Category: Medicine
Subcategory: Neurology (clinical)
Q114 / 400
Category: Medicine
Subcategory: Cell Biology
Q132 / 285

自引率 (2023-2024)7.10%自引率趨勢
掲載範囲
Aging & Disease (A&D) is a peer reviewed, open access online journal that aspires to publish novel and high-impact findings on central issues pertaining to the biology of aging, pathophysiology of age-related diseases, and innovative therapies for diseases afflicting the elderly population. The diseases of interest include (but not limited to) Stroke, Alzheimer's disease, Parkinson’s disease, Epilepsy, Dementia, Depression, Cardiovascular Disease, Cancer, Arthritis, Cataract, Osteoporosis, Diabetes and Hypertension. Studies on animal models as well as human tissues or cells are welcome.
官方網站http://www.aginganddisease.org/EN/2152-5250/home.shtml
在線稿件提交http://www.aginganddisease.org/EN/2152-5250/home.shtml
開放訪問Yes
出版商International Society on Aging and Disease
主題領域GERIATRICS & GERONTOLOGY
出版國/地區UNITED STATES
發行頻率
創刊年0
每年文章數220每年文章數趨勢
黃金OA百分比89.82%
OA Related Info
APC: Yes( USD2000; )
APC waiver:Check Notes
Other charges: No
Keywords: biology of aging、geriatrics、aging-associated diseases、alzheimer's disease、parkinson's disease、dementia
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardPeer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
GERIATRICS & GERONTOLOGYSCIEQ16/74
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2152-5250%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 10 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Aging and Disease】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE641174
    BIOMATERIALS580543
    BIOMEDICINE & PHARMACOTHERAPY498397
    Frontiers in Pharmacology489759
    JOURNAL OF ETHNOPHARMACOLOGY479946
    Journal of Materials Chemistry B476069
    Frontiers in Immunology458218
    COLLOIDS AND SURFACES B-BIOINTERFACES419267
    COMPUTERS IN BIOLOGY AND MEDICINE416797
    Frontiers in Oncology413603
  •  

    Aging and Disease Aging and Disease
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/8)
  [Aging and Disease] 的評論撰寫評論
作者: 仲夏琳贺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-25 11:32:21 評論於
How long does it usually take to wait for a review assignment?
(0) 讚! | 仲夏琳贺

作者: 仲夏琳贺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-23 10:29:48 評論於
Have you received it? What original data do we need to submit next? Thank you
(0) 讚! | 仲夏琳贺

作者: 魔都小柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-26 11:22:36 評論於
The impact factor and aging cell are the same, and Nature Aging rejected the latter
(0) 讚! | 魔都小柔

作者: 龟甲星雨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-18 17:48:43 評論於
Is "Awaiting Reviewer Assignment" indicating the review process has been passed to external reviewers?
(0) 讚! | 龟甲星雨

作者: 碧桃书容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-18 08:36:56 評論於
This should be finding reviewers
(0) 讚! | 碧桃书容

作者: 碧桃书容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-12 10:41:20 評論於
How long will it take after rework for awaiting EIC decision?
(0) 讚! | 碧桃书容

作者: 穿心天瑞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-10 13:11:54 評論於
The period is also just two or three months
(0) 讚! | 穿心天瑞

作者: 碧桃书容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-09 21:07:04 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 25.0
Experience Sharing: 12.18
Submitted on 1.9, first review completed. The reviewer had a good attitude and provided relatively gentle comments, but significant revisions are needed. Revised on 2.29, awaiting reviewer score on 3.1, and still awaiting EIC decision on 3.10. Still no news!
(0) 讚! | 碧桃书容

作者: 四象兴文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-13 19:42:36 評論於
Emphasized research direction: cerebrovascular disease. Sharing of experiences: Is this journal peer-reviewed?
(0) 讚! | 四象兴文

作者: 坂田秋荷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-05 12:47:17 評論於
Is there any follow-up?
(0) 讚! | 坂田秋荷

作者: 风啸彦红


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-27 18:40:35 評論於
Waiting
(0) 讚! | 风啸彦红

作者: 神古辰沛


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-24 10:03:04 評論於
 (0) 讚! | 神古辰沛  

作者: 西风良奥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-18 15:02:11 評論於
Hello, will it be rejected after this status?
(0) 讚! | 西风良奥

作者: 是你的蕴涵呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-04 13:24:18 評論於
Not yet invested
(0) 讚! | 是你的蕴涵呀

作者: 雾都玉莆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-26 20:39:11 評論於
Hello, how have you been lately?
(0) 讚! | 雾都玉莆

作者: 雾都玉莆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-26 12:04:14 評論於
Hello, have you finally been rejected? I've been in this state for 4 days now
(0) 讚! | 雾都玉莆

作者: 八卦明熙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-03 22:46:54 評論於
Hello, did you get rejected? I applied around the same time as you
(0) 讚! | 八卦明熙

作者: 易筋翠柏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-16 14:17:08 評論於
Help, have you all been rejected in this state?
(0) 讚! | 易筋翠柏

作者: 易筋翠柏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-16 12:30:46 評論於
Did you experience rejection or approval at this stage? I just applied 2 days ago and I'm feeling so frustrated
(0) 讚! | 易筋翠柏

作者: 蒙德青文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-14 10:46:50 評論於
This status needs to be rejected, quickly prepare for the next one
(0) 讚! | 蒙德青文

作者: 不灭淑宁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-30 23:02:57 評論於
It has been a week since my major overhaul, and it has been awaiting review assignment the whole time. Is this normal?
(0) 讚! | 不灭淑宁

作者: 不灭淑宁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-30 15:08:19 評論於
It's been a week since the major revision, are we still waiting for the assignment of review experts, is it mean to change the reviewer?
(0) 讚! | 不灭淑宁

作者: 魔都小柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-29 14:56:14 評論於
9.9
(0) 讚! | 魔都小柔

作者: 耶达坎普


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-29 14:14:59 評論於
Don't you think that Chinese people should be strict in reviewing manuscripts? Even though I am Chinese
(0) 讚! | 耶达坎普

作者: 凌霄彭薄


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-10 14:58:59 評論於
I also submitted my work, but it was rejected after three days. The editor said there were too many submissions recently
(0) 讚! | 凌霄彭薄

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/8)

開始撰寫 [Aging and Disease] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*